KASERTA Trademark

Pharmaceutical preparations for the treatment of infectious diseases; Therapeutic preparations, namely, antimicrobial and bacteriophage-based therapies for the treatment of infectious diseases; Pharmaceutical preparations comprised of bacteriophages for the treatment of bacterial infections, antimicrobial-resistant bacterial infections, diabetic foot infections, wound infections, and skin and soft tissue infections; Topical antimicrobial pharmaceutical preparations comprised of bacteriophages; Medicated topical preparations for the treatment of infected wounds; Medicated foot creams

Providing scientific data analysis and research services using pathogen surveillance, antimicrobial resistance, genomic, phenotypic, and epidemiological data to support pharmaceutical development, clinical trial planning, commercialization, and deployment of antimicrobial and bacteriophage-based therapies; Providing temporary use of non-downloadable software for collecting, analyzing, and providing pathogen surveillance data and antimicrobial resistance information; Software as a service (SaaS) featuring software for clinical decision support in the selection and optimization of antimicrobial and bacteriophage-based treatments; Platform as a service (PaaS) featuring software platforms for integrating infectious disease surveillance, therapeutic design, and treatment outcome tracking; Providing medical and scientific research information in the field of infectious diseases and antimicrobial resistance; Scientific data analysis and research services; Bioinformatics services